Clinical Trial

Giessen Pulmonary Hypertension in Lung Cancer Registry

Study acronym: PHLHR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 1, 2025 (before its estimated January 29, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-07-08; most recent amendment 2025-03-26.
Trial Details
NCT Number NCT04467333
Lead Sponsor University of Giessen
Conditions Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment 500 participants
Start Date 2020-06-29
Primary Completion 2026-01-29 (estimated)
Study Completion 2040-01-29 (estimated)
Updated on ClinicalTrials.gov 2025-04-01